The sample was not returned.The finished product met all specifications prior to being released for general distribution.The instructions for use which accompanies all devices currently addresses potential risks associated with surgically implanted materials.The instructions for use states in the adverse events: ¿potential adverse reactions are those typically associated with surgically implantable materials, including hematoma, seroma, mucosal or visceral erosion, infection, inflammation, sensitization, dyspareunia, scarification and contraction, fistula formation, extrusion and recurrence of vaginal wall prolapse.Perforations or lacerations of vessels, nerves, bladder, bowel, rectum, or any viscera may occur during needle passage." (b)(4).
|
It was reported by the patient¿s attorney that as a result of having the product implanted, the patient has experienced pain, laceration of internal body tissue and organs, dyspareunia, dysuria, painful/permanent scarring, permanent bodily disfigurement, impairment/damage, sequelae, erosion of internal bodily tissue, injury, additional surgeries and corrective treatment.Product was used for therapeutic treatment.Per additional information received, the patient has experienced vaginal mesh extrusion, reproducible pain with palpitation, dyspareunia, vaginal pain, rectocele, attenuated rectovaginal fascia, mesh erosion through rectal mucosa, foreign material present, focal giant cell reaction, mesh exposure, rectocele without mention of uterine prolapse, anovaginal fistula, perirectal hematoma, questionable abscess, acute pain, swelling in the vaginal and right buttock cheek and perineal area, and required surgical and non-surgical interventions.
|